About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Head, National Field Medical (Head) is a senior leader responsible for shaping and executing the US field medical strategy in oncology across multiple tumor types. Reporting to the SVP, Global Medical Affairs, the Head will oversee two-tier field teams of Medical Science Directors (RMSDs), each leading field engagement within defined US regions, managed by regional leads. This individual will build scalable capabilities to enable launch excellence, drive scientific and operational effectiveness, and ensure support for pipeline developments in multiple oncological indications. Highly action oriented, the Head will partner cross-functionally with Medical Affairs, Commercial, Clinical Development, Clinical Operations, Market Access, and other teams to ensure effective, fair, balanced, and compliant interactions with HCPs, KOLs, and decision makers advancing disease and product knowledge and understanding.
Role and Responsibilities:
Experience, Education and Specialized Knowledge and Skills:
This is the pay for this position
Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Leads global pharmacovigilance regulatory assessments and translates requirements into procedures, operational processes, and readiness plans that support compliance across existing and new markets.
Lead a connected patient experience strategy across care, onboarding, ongoing support, and community engagement, partnering with DTP and cross-functional teams to improve the patient journey.
Leads territory strategy and the full sales cycle to acquire new clients, grow market presence, and build prospective client and supplier-partner relationships in the mobility industry.
Leads relationships with European partner organizations and develops public sector strategies, partnerships, and learning initiatives to strengthen education programs, expand their impact, and advance regional collaboration.
As Executive Creative Director, you will set the creative vision for a major health and wellness account, focusing on women's health and leading multidisciplinary teams.
